subject: Belgium In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012----Aarkstore Enterprise Market Research Aggregation [print this page]

---

Belgium In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Belgium In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market market in Belgium

Scope

- The report provides information on the Belgian in vitro diagnostics market, broken down into detailed categories and segments such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.

- Total revenues, end users

- Market shares of all the key competitors.

- Key pipeline products that are set to shape the market, broken down by sector.

- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.

- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.

- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.

- Key mergers and acquisitions, partnerships, private equity investments and IPOs.

- Customer, hospitals and physicians data. 1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

3 Definitions of the Markets Covered in the Report

3.1 In Vitro Diagnostics

3.2 Clinical Chemistry

3.3 Genetic Testing

3.4 Haematology

3.5 Histology And Cytology

3.6 Immuno Chemistry

3.7 Infectious Immunology

3.8 Microbiology Culture

4 Healthcare Sector Review

4.1 Healthcare Expenditure

4.2 Healthcare Infrastructure

4.3 Healthcare Policy

5 Regulation System

5.1 Medical Equipment Approval Process

5.2 Notification Fee

6 Pricing and Reimbursement

6.1 Reimbursement Policies

7 Distribution Structure

8 In Vitro Diagnostics In Belgium

8.1 In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), 2000-2015

8.2 In In Vitro Diagnostics, Belgium, Company Share (2007-2008)

9 Clinical Chemistry In Belgium

9.1 Clinical Chemistry Overall Revenue (2000-2015)

9.2 Clinical Chemistry Distribution Share (2007-2008)

9.3 Clinical Chemistry, Belgium, Company Share (2007-2008) For more information, please visit :

http://www.aarkstore.com/reports/Belgium-In-Vitro-Diagnostics-Investment-Opportunities-Analysis-and-Forecasts-to-2012-8897.html

Or email us at press@aarkstore.com or call +919272852585

Belgium In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012----Aarkstore Enterprise Market Research Aggregation

By: Aarkstore Enterprise

---

welcome to loan (http://www.yloan.com/)

Powered by Discuz! 5.5.0